Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · IEX Real-Time Price · USD
6.17
+0.13 (2.15%)
At close: Mar 28, 2024, 4:00 PM
6.05
-0.12 (-1.94%)
After-hours: Mar 28, 2024, 6:02 PM EDT

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-57.51-161.82-122.25-149.91-193.64-146.65-101.98-55.66-19.2-5.23
Upgrade
Depreciation & Amortization
9.2110.119.849.989.25.582.160.780.590.28
Upgrade
Share-Based Compensation
9.817.1916.4114.319.5115.612.146.544.020
Upgrade
Other Operating Activities
19.086.737.019.65-23.3102.614.0116.412.060.52
Upgrade
Operating Cash Flow
-19.43-127.78-88.99-115.98-188.23-22.86-83.67-31.93-12.53-4.43
Upgrade
Capital Expenditures
-1.12-1.26-0.56-1.34-3.92-9.94-18.89-5.56-1.86-0.58
Upgrade
Change in Investments
0000000000.32
Upgrade
Other Investing Activities
---------1.06-
Upgrade
Investing Cash Flow
-1.12-1.26-0.56-1.34-3.92-9.94-18.89-5.56-2.91-0.26
Upgrade
Share Issuance / Repurchase
132.5352.9255.83154.54164.465.1194.4430.26113.085.59
Upgrade
Debt Issued / Paid
00000-0.02-0.06-0.06-0.130
Upgrade
Other Financing Activities
-14.27------1.0862.640.03
Upgrade
Financing Cash Flow
132.5367.1955.83154.54164.465.0994.3729.12175.595.62
Upgrade
Exchange Rate Effect
-0.1-0.21-0.210.120.110.040.4-0.010.02-0.33
Upgrade
Net Cash Flow
111.89-62.06-33.9337.34-27.6432.33-7.78-8.38160.170.61
Upgrade
Free Cash Flow
-20.55-129.04-89.55-117.32-192.15-32.8-102.56-37.49-14.38-5
Upgrade
Free Cash Flow Margin
-18.13%-3536.20%-218.61%-584.35%-1202.21%-227.56%-2634.42%-3432.97%-9463.16%-
Upgrade
Free Cash Flow Per Share
-0.19-1.64-1.73-2.99-5.67-1.13-3.87-1.64-1.37-1.28
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).